Company Overview and News

0
Heineken seeks legal advice on appointing United Breweries chairman: Report

2018-07-17 moneycontrol
Dutch beer-maker Heineken has sought legal advice on appointing a chairman at United Breweries, according to an Economic Times report.
UBL UBHOLDINGS 507458 UNBWY 532478

0
Vijay Mallya money laundering case: Police identifies 159 properties but could not attach them

2018-07-05 freepressjournal.in
New Delhi: The Bangalore police today informed a Delhi court that it has identified 159 properties belonging to liquor baron Vijay Mallya, but has not been able to attach any of them for the Enforcement Directorate’s (ED) money laundering case relating to FERA violations.
UBL UBHOLDINGS 507458 UNBWY 532478

0
USL, GM Breweries, Pincon Spirit fall 5-6% after Karnataka govt raises excise duty on liquor

2018-07-05 moneycontrol
Share prices of all listed liquor companies fell up to 6 percent intraday on Thursday after the Karnataka government increased additional excise duty on liquor.
532432 538771 PINCON UBL UNITDSPR UQNTY UBHOLDINGS GLOBUSSPR 507458 UNBWY 532478 533104

1
Closing Bell: Banks, RIL lift Sensex 267 pts; Nifty ends above 10,750 despite weak Asia

2018-07-04 moneycontrol
Global Update: Asian markets ended in the red with China's Shanghai Composite losing a percent after recording gains in the previous session. Trade tensions remained in the spotlight ahead of a looming tariff deadline, reports CNBC.
BAJAJ-AUTO KOHINOOR MUTHOOTFIN BHRYY 500325 UBL RELIANCE 532978 532977 533398 SRTRANSFIN 532478 511218 532783 532187 532121 506690 534816 RIGD SRRQY HDFCBANK BJJQY INFRATEL RLNIY 500034 UNICHEMLAB INDUSINDBK UBHOLDINGS 539126 UNBWY MEP 512559 BAJAJFINSV BAJFINANCE HDB 500180 DENABANK 507458 DAAWAT

0
Market Live: Nifty at day#39;s high, Sensex up over 250 pts; Bajaj Auto, Bharti Infratel top gainers

2018-07-04 moneycontrol
Buzzing: Unichem Laboratories share price rallied more than 5 percent intraday after the company received final ANDA approval for its Montelukast Chewable tablets, 4 mg and 5 mg from the United States Food and Drug Administration to market in the US.
BAJAJ-AUTO KOHINOOR BHRYY 500325 UBL RELIANCE 532978 532977 SRTRANSFIN 532478 511218 532783 532121 506690 534816 RIGD SRRQY BJJQY INFRATEL RLNIY 500034 UNICHEMLAB UBHOLDINGS UNBWY 512559 506022 BAJAJFINSV BAJFINANCE PRAKASH DENABANK 507458 DAAWAT

4
Market Live: Sensex up 150 pts despite global weakness; HDFC twins, RIL lead

2018-07-04 moneycontrol
Europe Update: European stocks were slightly lower Wednesday morning, amid elevated tensions between the US and China over looming trade tariffs and investment restrictions.
BAJAJ-AUTO KOHINOOR 500325 533271 UBL RELIANCE ASHOKA 532978 532977 532712 SRTRANSFIN 532478 511218 532783 500470 532121 RCOM RIGD SRRQY BJJQY 500570 TATAMOTORS 509488 RLNIY 500034 GRAPHITE UBHOLDINGS 532967 UNBWY KIRIINDUS BHEL 512559 506022 BAJAJFINSV BAJFINANCE TTST TATASTEEL TATLY PRAKASH BRHTY 500103 DENABANK 507458 DAAWAT TTM

0
UB shares drop 1.5% on Goldman Sachs 'neutral' rating

2018-07-04 thehindubusinessline
United Breweries's NSE-listed shares dropped as much as 1.5 per cent to Rs 1,151 in thin trade. Goldman Sachs has initiated coverage on the stock with a “neutral” rating and a price target of Rs 1,171.
UBL UBHOLDINGS 507458 UNBWY 532478

0
United Breweries down 3%, Goldman Sachs neutral with target Rs 1,171

2018-07-04 moneycontrol
Shares of United Breweries declined 3 percent intraday Wednesday as foreign research house Goldman Sachs has initiated neutral call on the company with a target of Rs 1,171 per share.
UBL UBHOLDINGS 507458 UNBWY 532478

4
Market Live: Rangebound trade continues at Dalal Street; Shriram Transport tumbles

2018-07-04 moneycontrol
Ducon Infratechnologies at upper circuit; Shares of Ducon Infratechnologies were locked at 20 percent upper circuit at Rs 22.80 following new orders for its US subsidiary.
BAJAJ-AUTO 500325 533271 UBL RELIANCE ASHOKA 532978 532977 532712 SRTRANSFIN 532478 511218 500470 532121 RCOM RIGD SRRQY BJJQY 500570 TATAMOTORS 509488 RLNIY 500034 GRAPHITE UBHOLDINGS 532967 UNBWY KIRIINDUS BHEL 506022 BAJAJFINSV BAJFINANCE TTST TATASTEEL TATLY PRAKASH BRHTY 500103 DENABANK 507458 TTM

5
Closing Bell: Sensex rises 114 pts, Nifty ends tad below 10,700; pharma, auto, IT outshine

2018-07-03 moneycontrol
Global Update: Asian stocks closed mixed as investors remained cautious ahead of a July 6 deadline when the US is set to impose tariffs on $34 billion worth of goods from China. Beijing is then expected to respond with charges of its own on US goods, reports CNBC.
500325 UBL TTQQY 532478 TATACHEM CADILAHC 532321 BJJQY 500570 500770 RLNIY 513010 AXB MRZUY 532500 AXBA BAJAJFINSV BAJFINANCE 532670 TATASTEEL TATLY MARUTI 500180 KOTAKBANK 507458 523204 SSWL 513262 533271 RELIANCE IDBI 532737 ASHOKA 532978 RENUKA 532215 ABAN 500470 AXISBANK RIGD TATASPONGE HDFCBANK NIHARINF TATAMOTORS 500034 500116 KMBKY TATAMETALI IBN UBHOLDINGS 513434 532967 KIRIINDUS UNBWY CDLYY AXBKY ICICIBANK TTST EMKAY HDB 532174 531083 500247 TTM

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...